HRP970519A2 - Medical treatment - Google Patents

Medical treatment

Info

Publication number
HRP970519A2
HRP970519A2 HR9619962.5A HRP970519A HRP970519A2 HR P970519 A2 HRP970519 A2 HR P970519A2 HR P970519 A HRP970519 A HR P970519A HR P970519 A2 HRP970519 A2 HR P970519A2
Authority
HR
Croatia
Prior art keywords
compound
formula
chlorophenyl
dimethyl
pharmaceutically acceptable
Prior art date
Application number
HR9619962.5A
Other languages
English (en)
Croatian (hr)
Inventor
Stephen Paul Jones
Original Assignee
Stephen Paul Jones
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stephen Paul Jones filed Critical Stephen Paul Jones
Publication of HRP970519A2 publication Critical patent/HRP970519A2/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
HR9619962.5A 1996-09-25 1997-09-25 Medical treatment HRP970519A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619962.5A GB9619962D0 (en) 1996-09-25 1996-09-25 Medical treatment

Publications (1)

Publication Number Publication Date
HRP970519A2 true HRP970519A2 (en) 1998-08-31

Family

ID=10800448

Family Applications (1)

Application Number Title Priority Date Filing Date
HR9619962.5A HRP970519A2 (en) 1996-09-25 1997-09-25 Medical treatment

Country Status (26)

Country Link
US (1) US6162831A (fr)
EP (1) EP1007023B1 (fr)
JP (1) JP2001501608A (fr)
KR (1) KR20000048568A (fr)
CN (1) CN1231604A (fr)
AT (1) ATE239460T1 (fr)
AU (1) AU722129B2 (fr)
BG (1) BG103278A (fr)
BR (1) BR9711414A (fr)
CA (1) CA2266438A1 (fr)
DE (1) DE69721838T2 (fr)
DK (1) DK1007023T3 (fr)
ES (1) ES2199374T3 (fr)
GB (1) GB9619962D0 (fr)
HR (1) HRP970519A2 (fr)
HU (1) HUP9904545A3 (fr)
IL (1) IL128851A (fr)
NO (1) NO991425D0 (fr)
NZ (1) NZ334668A (fr)
PL (1) PL332423A1 (fr)
PT (1) PT1007023E (fr)
SK (1) SK32199A3 (fr)
TR (1) TR199900649T2 (fr)
TW (1) TW415842B (fr)
WO (1) WO1998013033A1 (fr)
ZA (1) ZA978573B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
EP1169027A4 (fr) * 1999-03-19 2004-10-20 Abbott Gmbh & Co Kg Traitement de l'arthrose
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US9655932B2 (en) * 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
NZ538966A (en) * 2002-10-05 2006-11-30 Hanmi Pharm Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
JP2008506785A (ja) * 2004-07-21 2008-03-06 フロリダ大学 リサーチファウンデーション インコーポレイティッド インスリン抵抗性の治療及び予防のための組成物及び方法
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
KR20080046601A (ko) * 2006-11-22 2008-05-27 에스케이케미칼주식회사 보관안정성이 우수한 시부트라민 함유 포접복합체
WO2018125735A1 (fr) 2016-12-29 2018-07-05 Kibow Biotech, Inc. Composition et procédé pour maintenir une fonction rénale saine
KR20210124958A (ko) * 2018-11-02 2021-10-15 앰퍼샌드 바이오파마슈티컬스, 인코포레이티드 국소적으로 적용되는 완충제(buffers)를 사용하는 양이온 과부하 및 전해질 불균형의 위험 가능성 관리를 위한 제형 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
AU4542893A (en) * 1992-06-23 1994-01-24 Sepracor, Inc. Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
WO1994000047A1 (fr) * 1992-06-23 1994-01-06 Sepracor Inc. Procedes et compositions utilises pour traiter la depression et d'autres affections avec de la sibutramine (+) optiquement pure
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
HUP9904545A2 (hu) 2000-11-28
SK32199A3 (en) 1999-12-10
CA2266438A1 (fr) 1998-04-02
IL128851A (en) 2001-08-26
PL332423A1 (en) 1999-09-13
DE69721838D1 (de) 2003-06-12
DE69721838T2 (de) 2004-01-22
GB9619962D0 (en) 1996-11-13
AU722129B2 (en) 2000-07-20
EP1007023A1 (fr) 2000-06-14
TR199900649T2 (xx) 1999-07-21
BG103278A (en) 2000-01-31
HUP9904545A3 (en) 2000-12-28
ATE239460T1 (de) 2003-05-15
NO991425L (no) 1999-03-24
US6162831A (en) 2000-12-19
WO1998013033A1 (fr) 1998-04-02
DK1007023T3 (da) 2003-08-25
TW415842B (en) 2000-12-21
PT1007023E (pt) 2003-08-29
NO991425D0 (no) 1999-03-24
BR9711414A (pt) 2000-04-25
JP2001501608A (ja) 2001-02-06
ES2199374T3 (es) 2004-02-16
AU4385197A (en) 1998-04-17
NZ334668A (en) 2000-07-28
CN1231604A (zh) 1999-10-13
KR20000048568A (ko) 2000-07-25
ZA978573B (en) 1999-03-25
IL128851A0 (en) 2000-01-31
EP1007023B1 (fr) 2003-05-07

Similar Documents

Publication Publication Date Title
US5459164A (en) Medical treatment
RU2197959C2 (ru) Применение аналогов сибутрамина для снижения уровней липидов
HRP970519A2 (en) Medical treatment
US6376552B1 (en) Treatment of gallstones
US6441046B1 (en) Control of metabolism
US6232347B1 (en) Treatment of osteoarthritis
AU773490B2 (en) Treatment of osteoarthritis
CA2367041A1 (fr) Traitement destine a reduire l'adhesivite plaquettaire
US20050113457A1 (en) Treatment of neuropathic pain or fibromyalgia
US6288125B1 (en) Treatment of hiatial hernia
WO2000056150A1 (fr) Traitement du syndrome premenstruel
US6433020B1 (en) Treatment of cardiovascular disease
CA2366652A1 (fr) Traitement de l'hypertension arterielle pulmonaire
WO2000056319A1 (fr) Traitement de l'hypotension orthostatique
US20020132856A1 (en) Treatment of premenstrual syndrome
AU3894400A (en) Treatment of hiatial hernia
CZ9901055A3 (cs) Léčivo a farmaceutická kompozice pro snižování hladiny kyseliny močové
CA2367045A1 (fr) Traitement de certains cancers associes a un gain de poids
CA2368416A1 (fr) Traitement des calculs biliaires

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBI Application refused